1. Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway
   YAN-GUI WANG et al, 2015 CrossRef
2. Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver
   Munkhtugs Davaatseren et al, 2013, Food and Chemical Toxicology CrossRef
3. Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.
   Xiang Wang et al, 2014, Mol Med Rep CrossRef
4. Endocannabinoid Interaction with Human FABP1: Impact of the T94A Variant
   Gregory G. Martin et al, 2017, Biochemistry CrossRef
5. Lavatera critica, a green leafy vegetable, controls high fat diet induced hepatic lipid accumulation and oxidative stress through the regulation of lipogenesis and lipolysis genes.
   Chinnadurai Veeramani et al, 2017, Biomed Pharmacother CrossRef
6. Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet
   Gregory G. Martin et al, 2017, J. Lipid Res. CrossRef
7. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations
   Charlotte J. Green et al, 2015, American Journal of Physiology-Endocrinology and Metabolism CrossRef
8. Ablating both Fabp1 and Scp2/Scpx (TKO) Induces Hepatic Phospholipid and Cholesterol Accumulation in High Fat-fed Mice
   Sherrelle Milligan et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
9. Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach
   Natalia Nuño-Lámbarri et al, 2016, IJMS CrossRef
10. Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System
    Gregory G. Martin et al, 2018, Lipids CrossRef
11. Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease
    Prahlad K. Rao et al, 2018, Clin Proteom CrossRef
12. Possible Mechanisms Underlying Fatty Liver in a Rat Model of Male Hypogonadism: A Protective Role for Testosterone
    Hussein F. Sakr et al, 2018, Steroids CrossRef
13. Neonatal overfeeding induced glucocorticoid overexposure accelerates hepatic lipogenesis in male rats
    Fan Yang et al, 2018, Nutr Metab (Lond) CrossRef
14. Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat
    Gregory G. Martin et al, 2018, Archives of Biochemistry and Biophysics CrossRef
15. Increased hepatic FAT/CD36, PTP1B and decreased HNF4A expression contributes to dyslipidemia associated with ethanol–induced liver dysfunction: Rescue effect of ginger extract
    Alireza Shirpoor et al, 2018, Biomedicine & Pharmacotherapy CrossRef
16. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.
    David Højland Ipsen et al, 2018, Cell Mol Life Sci CrossRef
17. Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels
    Gregory G. Martin et al, 2016, Lipids CrossRef
18. Hepatic lesions induced by feeding Western diets to Zucker fatty rats, an insulin-resistant model
    Tomoyuki Saito et al, 2018, J Toxicol Pathol CrossRef
19. Protective Actions of Polyphenols in the Development of Nonalcoholic Fatty Liver Disease
    Yoojin Lee et al, 2019 CrossRef
20. A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans
    Evelina Charidemou et al, 2019 CrossRef
21. Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings
    Carola Schedlbauer et al, 2019 CrossRef
22. Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice
    Mi-Young Park et al, 2013, Nutr Res Pract CrossRef
23. Eicosanoids in Metabolic Syndrome
    James P. Hardwick et al, 2013 CrossRef
24. A specificStreptococcus mutansstrain aggravates non-alcoholic fatty liver disease
    S Naka et al, 2014, Oral Dis CrossRef
25. Mechanisms underlying hypertriglyceridemia in rats with monosodium l-glutamate-induced obesity: Evidence of XBP-1/PDI/MTP axis activation
    Lucas Martins França et al, 2014, Biochemical and Biophysical Research Communications CrossRef
26. Low LDL-C and High HDL-C Levels Are Associated with Elevated Serum Transaminases amongst Adults in the United States: A Cross-sectional Study
    Zhenghui Gordon Jiang et al, 2014, PLoS ONE CrossRef
27. Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variant
    Huan Huang et al, 2014, FEBS J CrossRef
28. Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition
    Minjie Lin et al, 2014, Drug Saf CrossRef
29. Houttuynia cordataalleviates high-fat diet-induced non-alcoholic fatty liver in experimental rats
    Hyun Kang et al, 2015, Pharmaceutical Biology CrossRef
30. Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis
    Ting Jiang et al, 2019, Toxicology Letters CrossRef
31. Dipeptidyl Peptidase-4 Inhibition Ameliorates Western Diet–Induced Hepatic Steatosis and Insulin Resistance Through Hepatic Lipid Remodeling and Modulation of Hepatic Mitochondrial Function
    Annayya R. Aroor et al, 2015, Diabetes CrossRef
32. Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine
    Maria Lúcia Bonfleur et al, 2015, Life Sciences CrossRef
33. Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female mice
    Gregory G. Martin et al, 2015, Archives of Biochemistry and Biophysics CrossRef
34. Molecular mechanisms of fatty liver in obesity
    Lixia Gan et al, 2015, Front. Med. CrossRef
35. Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats
    Mao Li et al, 2016, PLoS ONE CrossRef
36. Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias
    Friedhelm Schroeder et al, 2016, Lipids CrossRef
37. FABP-1 gene ablation impacts brain endocannabinoid system in male mice.
    Gregory G Martin et al, 2016, J Neurochem CrossRef
38. Fabp1gene ablation inhibits high-fat diet-induced increase in brain endocannabinoids
    Gregory G. Martin et al, 2017, J. Neurochem. CrossRef
39. The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
    Leanne Hodson et al, 2019, Nat Rev Endocrinol CrossRef
40. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
    Somaya Albhaisi et al, 2019, Pharm Med CrossRef
41. Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice.
    Ting-Chen Chang et al, 2019, BMC Complement Altern Med CrossRef
42. Programming of hepatic lipid metabolism in a rat model of postnatal nicotine exposure – Sex-related differences
    Iala Milene Bertasso et al, 2019, Environmental Pollution CrossRef
43. Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
    Ines C.M. Simoes et al, 2019, Nutrients CrossRef
44. A non-obese, diet-induced animal model of nonalcoholic steatohepatitis in Wistar/ST rats compared to Sprague-Dawley rats
    Katsuhisa Omagari et al, 2020, Clinical Nutrition Experimental CrossRef
45. High Glucose and Liver Fatty Acid Binding Protein Gene Ablation Differentially Impact Whole Body and Liver Phenotype in High‐Fat Pair‐Fed Mice
    Gregory G. Martin et al, 2020, Lipids CrossRef
46. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis
    Pippa J. Gunn et al, 2020, Physiol Rep CrossRef
47. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis
    Ankita Chatterjee et al, 2020, Annals of Hepatology CrossRef
48. Effects of dietary fibres on gut microbial metabolites and liver lipid metabolism in growing pigs
    Yaolian Hu et al, 2020, J Anim Physiol Anim Nutr CrossRef
49. Germinated Soybean Embryo Extract Ameliorates Fatty Liver Injury in High-Fat Diet-Fed Obese Mice
    Doyoung Kwon et al, 2020, Pharmaceuticals CrossRef
50. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
    Kalliopi Pafili et al, 2020, Molecular Metabolism CrossRef
51. Protective Effects of Voluntary Exercise on Hepatic Fat Accumulation Induced by Dietary Restriction in Zucker Fatty Rats
    Yuka Kurosaka et al, 2021, IJMS CrossRef
52. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
    Agnieszka Karkucinska‐Wieckowska et al, 2021, Eur J Clin Invest CrossRef
53. Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
    Michele Biagioli et al, 2021, Liver Research CrossRef
54. The role of hepatic lipid composition in obesity‐related metabolic disease
    Scott A. Willis et al, 2021, Liver Int CrossRef
55. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
    Tingfeng Wu et al, 2021, Front. Endocrinol. CrossRef
56. Polyene Phosphatidylcholine Ameliorates High Fat Diet-Induced Non-alcoholic Fatty Liver Disease via Remodeling Metabolism and Inflammation
    Yang Lu et al, 2022, Front. Physiol. CrossRef
57. Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study.
    Ming-Shyan Lin et al, 2016, Obes Facts CrossRef
58. Clinically Relevant Dose of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα), Lowers Serum Triglyceride Levels by Targeting Hepatic PPARα in Mice
    Zhe Zhang et al, 2022, Biomedicines CrossRef
59. Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
    Samuel K Handelman et al, 2022, Hepatol Commun CrossRef
60. A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease
    Erin Nicole Young et al, 2022, IJMS CrossRef
61. Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
    Willemien van Zwol et al, 2022, Hepatology CrossRef
62. Myclobutanil-mediated alteration of liver-gut FXR signaling in mice
    Rulaiha Taylor et al, 2022 CrossRef
63. Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease
    Divyavani Gowda et al, 2023, Livers CrossRef
64. Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic
    Guocheng Rao et al, 2023, Front. Med. CrossRef
65. Genome-Wide Association (GWAS) Applied to Carcass and Meat Traits of Nellore Cattle
    Hugo Borges Dos Reis et al, 2023, Metabolites CrossRef
66. Comparative Study on the Effects of Four Plant Protein Sources on the Liver and Intestinal Health of Largemouth Bass, Micropterus salmoides
    Shibin Yao et al, 2024, Aquaculture Nutrition CrossRef
67. Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
    Takahiro Kodama et al, 2024, Semin Liver Dis CrossRef
68. Nutraceutical and Dietary Measures with Potential for Preventing/Controlling Non-Alcoholic Fatty Liver Disease and Its Complications
    Lidianys Lewis Lujan et al, 2024, Human Nutrition & Metabolism CrossRef
69. Roles of FABPs on endocannabinoid transport and metabolism
    Asim K. Duttaroy, 2024 CrossRef
70. “Regulation of adipose-derived fatty acid fluxes to the liver”-Impact on Metabolic dysfunction-associated steatotic liver disease
    Erika Folestad et al, 2024, Current Opinion in Endocrine and Metabolic Research CrossRef
71. Dietary bile acids alleviate corticosterone-induced fatty liver and hepatic glucocorticoid receptor suppression in broiler chickens
    Jie Liu et al, 2024 CrossRef
72. Coriandrum sativum L. Leaf Extract Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating the AMPK Pathway in High Fat-Fed C57BL/6 Mice
    Min Ji Gu et al, 2024, Nutrients CrossRef
73. Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
    Melchor Alpízar Salazar et al, 2025, Medicina CrossRef
74. The ins and outs of liver fat metabolism: The effect of phenotype and diet on risk of intrahepatic triglyceride accumulation
    Kieran Smith et al, 2025, Experimental Physiology CrossRef